Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

Icosapent ethyl (Vascepa) demonstrated significant, 17 percent regression of low attenuation plaque (LAP) volume on multidetector computed tomography (MDCT) compared with placebo over 18 months in the EVAPORATE Trial

News | Pharmaceuticals

Icosapent Ethyl Significantly Reduces Coronary Plaque in EVAPORATE Study

September 10, 2020 - Icosapent ethyl (Vascepa) demonstrated significant, 17 percent regression of low attenuation plaque ...

September 10, 2020

The Opimax TiNO bio-active coated stent made by Hexacath.

News

Optimax Nitride-oxide Coated Stent Superior to Synergy Drug-eluting Stent in TIDES-ACS Trial

September 5, 2020 – The TIDES-ACS Randomized Controlled Trial results were published end of July 2020 confirming the ...

September 10, 2020

Biotronik's closed loop stimulation (CLS) technology helps reduce unexplained fainting in patients with recurrent episodes due to skipped heartbeats. #ESC2020

News | EP Lab

Study Shows Severe Fainting Can Be Treated with Cardiac Pacing Supported by Closed Loop Stimulation

September 8, 2020 - A new study presented at the 2020 European Society of Cardiology (ESC) Congress shows that Biotronik ...

September 08, 2020

News | Coronavirus (COVID-19)

First Randomized Trial Backs Safety of ACE and ARB Heart Drugs in COVID-19 Patients

September 8, 2020 - Heart patients hospitalized with COVID-19 (SARS-CoV-2) can safely continue taking angiotensin ...

September 08, 2020

Abbott Espirit BTK Bioresorbable stent, or bioresorbable vascular scaffold (BVS) measures 99 microns and is made from poly-L-lactide (PLLA), a semi-crystalline bioresorbable polymer engineered to resist vessel recoil and provide a platform for drug delivery. Abbott Absorb

Feature | Stents Bioresorbable

Abbott Restarts Bioresorbable Stent Clinical Trials With New Esprit Below-the-knee Scaffold

September 3, 2020 — Abbott today announced the start of the LIFE-BTK clinical trial to evaluate the safety and ...

September 03, 2020

Tailor PCI trial showed genetic testing may play a role in personalizing antiplatelet therapy after PCI.

News | Antiplatelet and Anticoagulation Therapies

Trial Shows Benefit of Using Genetic Testing to Tailor Antiplatelet Therapy

September 2, 2020 — An international, first-of-its-kind cardiology trial used personalized genetic testing to reduce by ...

September 02, 2020

Echocardiography strain imaging at ASE. #ASE2020

News | ASE

ASE Features Top 20 Echocardiography Research Abstract Presentations

August 20, 2020 – More than 350 posters featuring cutting edge research on the advances in cardiovascular ultrasound ...

August 20, 2020

The World Alliance of Societies of Echocardiography (WASE) Normal Values Study is a cross-sectional study designed to obtain universal global reference ranges for both 2-D and 3-D echocardiographic (2DE, 3DE) data to identify geographical differences in echocardiographic measurements. Launched in 2016, the WASE study prospectively enrolled healthy individuals free from cardiac, lung, and kidney disease from 19 centers in 15 countries. #ASE #ASE2020

News | Cardiovascular Ultrasound

WASE Study Finds Differences in How Right Atrial Size is Reported in Non-Asian and Asian Patients

August 20, 2020 – The World Alliance of Societies of Echocardiography (WASE) Normal Values Study is a cross-sectional ...

August 20, 2020

News | Heart Failure

Photo of Eyes Predicts Death and Readmission in Heart Failure Patients

August 17, 2020 — Pupil size predicts death and hospital readmission in patients with heart failure, according to r ...

August 17, 2020

Videos | CT Angiography (CTA)

VIDEO: Key Cardiac CT Papers Presented at SCCT 2020

Todd Villines, M.D., FACC, FAHA, MSCCT, explains some of most influential cardiac CT clinical papers from the past year ...

August 11, 2020

The TactiFlex PAF investigational device exemption (IDE) study will evaluate he investigational TactiFlex Ablation Catheter, Sensor Enabled (SE) to treat people suffering from paroxysmal atrial fibrillation (PAF).

News | Atrial Fibrillation

Study Evaluates Location Sensor Technology to Improve AFib Ablation Guidance

August 4, 2020 — Abbott announced the first enrollments in the TactiFlex PAF investigational device exemption (IDE) ...

August 04, 2020

Examples of allogeneic cardiac cells (also called cardiosphere-derived cells or CDCs).

News | Heart Failure

Three Years After Stem Cell Trial for Heart Failure was Abandoned New Evidence Shows it Works

August 4, 2020 - More than three years after a clinical trial was prematurely ended for failing to show progress in ...

August 04, 2020

News | Cardiogenic Shock

Large Study in Japan Finds High Survival Rates With Impella Heart Pump

August 3, 2020 — A three-year, investigator-led, prospective study of Japanese patients who received an Impella heart ...

August 03, 2020

Dapagliflozin (Farxiga) heart failure drug performs very will to improve outcomes for patients with chronic kidney disease.

News | Pharmaceuticals

Dapagliflozin Meets All Endpoints to Treat Chronic Kidney Disease

July 28, 2020 — AstraZeneca's heart failure medication dapagliflozin (Farxiga) significantly reduced the worsening of ...

July 28, 2020

News | Stents

CeloNova Completes Enrollment of First Randomized 14-Day DAPT Trial For a Stent

July 24, 2020 — CeloNova BioSciences Inc. announced it successfully completed enrollment of the COBRA REDUCE randomized ...

July 24, 2020